Table: Garna Biosciences - 9-MTH group results

Carna Biosciences

09/11/2018 06:30

Nov 9 (Reuters)- 
             Garna Biosciences Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Sep 30, 2018        Sep 30, 2017      Dec 31, 2018  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            586 mln             483 mln            1.19      
                 (+21.4 pct)         (-16.8 pct)       (+81.1 pct)  
  Operating     loss 762 mln        loss 477 mln      loss 679 mln  
  Recurring     loss 773 mln        loss 486 mln      loss 694 mln  
  Net           loss 822 mln        loss 508 mln      loss 758 mln  
  EPS          loss 85.82 yen      loss 54.46 yen    loss 79.39 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Garna Biosciences Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T